|
Name |
Drechmerin C
|
Molecular Formula | C33H45NO5 | |
IUPAC Name* |
(1S,2S,5S,7S,9R,10S,11R,14S)-9-hydroxy-1,2-dimethyl-7-[2-(3-methylbut-2-enoxy)propan-2-yl]-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-16(24),17,19,21-tetraene-10-carboxylic acid
|
|
SMILES |
CC(=CCOC(C)(C)[C@@H]1C[C@H]([C@]2([C@@H]3CC[C@H]4CC5=C([C@@]4([C@]3(CC[C@@H]2O1)C)C)NC6=CC=CC=C56)C(=O)O)O)C
|
|
InChI |
InChI=1S/C33H45NO5/c1-19(2)14-16-38-30(3,4)27-18-25(35)33(29(36)37)24-12-11-20-17-22-21-9-7-8-10-23(21)34-28(22)32(20,6)31(24,5)15-13-26(33)39-27/h7-10,14,20,24-27,34-35H,11-13,15-18H2,1-6H3,(H,36,37)/t20-,24+,25+,26-,27-,31-,32+,33-/m0/s1
|
|
InChIKey |
WROMAJJMNFVDNS-KFTNNUSKSA-N
|
|
Synonyms |
Drechmerin C
|
|
CAS | NA | |
PubChem CID | 139590921 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 535.7 | ALogp: | 6.6 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 91.8 | Aromatic Rings: | 6 |
Heavy Atoms: | 39 | QED Weighted: | 0.398 |
Caco-2 Permeability: | -5.186 | MDCK Permeability: | 0.00001620 |
Pgp-inhibitor: | 0.899 | Pgp-substrate: | 0.956 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.017 |
30% Bioavailability (F30%): | 0.068 |
Blood-Brain-Barrier Penetration (BBB): | 0.693 | Plasma Protein Binding (PPB): | 94.38% |
Volume Distribution (VD): | 1.271 | Fu: | 4.12% |
CYP1A2-inhibitor: | 0.041 | CYP1A2-substrate: | 0.369 |
CYP2C19-inhibitor: | 0.047 | CYP2C19-substrate: | 0.779 |
CYP2C9-inhibitor: | 0.455 | CYP2C9-substrate: | 0.319 |
CYP2D6-inhibitor: | 0.035 | CYP2D6-substrate: | 0.294 |
CYP3A4-inhibitor: | 0.564 | CYP3A4-substrate: | 0.677 |
Clearance (CL): | 5.213 | Half-life (T1/2): | 0.061 |
hERG Blockers: | 0.831 | Human Hepatotoxicity (H-HT): | 0.806 |
Drug-inuced Liver Injury (DILI): | 0.046 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.942 | Maximum Recommended Daily Dose: | 0.906 |
Skin Sensitization: | 0.272 | Carcinogencity: | 0.581 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.984 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003933 | 0.788 | D0H4JM | 0.317 | ||||
ENC004710 | 0.669 | D0X7XG | 0.278 | ||||
ENC001931 | 0.600 | D0U7GP | 0.271 | ||||
ENC000857 | 0.598 | D01JGV | 0.271 | ||||
ENC005883 | 0.595 | D0OT9S | 0.265 | ||||
ENC003874 | 0.587 | D06CWH | 0.255 | ||||
ENC002707 | 0.565 | D04RLY | 0.254 | ||||
ENC005405 | 0.515 | D09QVV | 0.249 | ||||
ENC005989 | 0.512 | D02IQY | 0.247 | ||||
ENC003172 | 0.512 | D0W2EK | 0.247 |